Candel Therapeutics, Inc. (CADL) vs Collegium Pharmaceutical, Inc. (COLL)
A side-by-side comparison of Candel Therapeutics, Inc. and Collegium Pharmaceutical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CADL
Candel Therapeutics, Inc.
$10.21HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
COLL
Collegium Pharmaceutical, Inc.
$22.15HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — CADL vs COLL
growth of $100 · dividends reinvested · last 5yCADL +46.1% (+7.9%/yr)COLL -11.7% (-2.5%/yr)CADL compounded faster over this window
CADL COLL
CADL vs COLL: by the numbers
- •CADL is the larger company ($748M vs $718M market cap).
- •COLL is profitable (5.93% net margin) while CADL runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CADL | COLL |
|---|---|---|
| P/E ratio | N/A | 17.86 |
| PEG ratio | N/A | 1.00 |
| P/S ratio | N/A | 0.89 |
| P/B ratio | 5.93 | 2.30 |
| EV / EBITDA | N/A | 2.86 |
| FCF yield | N/A | 45.70% |
Profitability
| Metric | CADL | COLL |
|---|---|---|
| Gross margin | 0.00% | 60.02% |
| Operating margin | 0.00% | 19.61% |
| Net margin | 0.00% | 5.93% |
| ROE | -70.19% | 15.36% |
| ROIC | -36.83% | 6.11% |
Growth (annualized)
| Metric | CADL | COLL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 19.91% |
| EPS CAGR (5Y) | N/A | 20.48% |
| FCF CAGR (5Y) | N/A | 26.38% |
| Total return CAGR (5Y) | -1.42% | 2.15% |
Frequently asked
- Is CADL or COLL more profitable?
- COLL runs the higher net margin — CADL at 0.00% versus COLL at 5.93%.
- How have CADL and COLL total returns compared?
- Over the past 5 years, CADL delivered -1.42% and COLL delivered 2.15% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Collegium Pharmaceutical P/E ratioCandel Therapeutics ROECollegium Pharmaceutical ROECandel Therapeutics operating marginCollegium Pharmaceutical operating marginCandel Therapeutics revenue growthCollegium Pharmaceutical revenue growthCandel Therapeutics free cash flowCollegium Pharmaceutical free cash flow
Candel Therapeutics & Collegium Pharmaceutical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.